A recent study confirms that the 100-year-old BCG vaccine does not protect against COVID-19, challenging early assumptions ...
Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...
ImmunityBio, Inc. , a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation's largest independent providers of urology and related specialty services, is one of the ...
Science Africa on MSN5h
Vaccination: Kenya Urged to Fulfil GAVI Co-financing ObligationBy Sharon AtienoKenya risks a vaccination crisis if the country does not honour its Global Alliance for Vaccines and ...
ET Now on MSN21h
Aurobindo's CuraTeq Biologics Aims Doubling Down on Biosimilar Launches - 2031 Plans REVEALED | ET NOW On The Go Hyderabad EditionAurobindo, that last year signed a deal with U.S. drugmaker MSD to manufacture one of their biologics products at its ...
People living with HIV are more than 14 times more likely to fall ill with TB disease than people without HIV.
Nadofaragene firadenovec intravesical gene therapy continues to show promise in treating BCG-unresponsive NMIBC bladder cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback